237 related articles for article (PubMed ID: 34829792)
1. Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases.
Murgia A; Ahmed Y; Sweeney K; Nicholson-Scott L; Arthur K; Allsworth M; Boyle B; Gandelman O; Smolinska A; Ferrandino G
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829792
[TBL] [Abstract][Full Text] [Related]
2. Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes.
Gaude E; Nakhleh MK; Patassini S; Boschmans J; Allsworth M; Boyle B; van der Schee MP
J Breath Res; 2019 May; 13(3):032001. PubMed ID: 30965287
[TBL] [Abstract][Full Text] [Related]
3. Exogenous Volatile Organic Compound (EVOC
Ferrandino G; Ricciardi F; Murgia A; Banda I; Manhota M; Ahmed Y; Sweeney K; Nicholson-Scott L; McConville L; Gandelman O; Allsworth M; Boyle B; Smolinska A; Ginesta Frings CA; Contreras J; Asenjo-Lobos C; Barrientos V; Clavo N; Novoa A; Riviotta A; Jerez M; Méndez L
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001958
[No Abstract] [Full Text] [Related]
4. Breath Tests to Assess Alcoholic Liver Disease.
Furnari M; Ahmed I; Erpecum KJ; Savarino V; Giannini EG
Rev Recent Clin Trials; 2016; 11(3):185-90. PubMed ID: 27515960
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
[TBL] [Abstract][Full Text] [Related]
6. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
7. Breath biomarkers for detection of human liver diseases: preliminary study.
Sehnert SS; Jiang L; Burdick JF; Risby TH
Biomarkers; 2002; 7(2):174-87. PubMed ID: 12101636
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 screening using breath-borne volatile organic compounds.
Chen H; Qi X; Zhang L; Li X; Ma J; Zhang C; Feng H; Yao M
J Breath Res; 2021 Oct; 15(4):. PubMed ID: 34624875
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive cancer detection using volatile biomarkers: Is urine superior to breath?
Becker R
Med Hypotheses; 2020 Oct; 143():110060. PubMed ID: 32683218
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath.
Verdam FJ; Dallinga JW; Driessen A; de Jonge C; Moonen EJ; van Berkel JB; Luijk J; Bouvy ND; Buurman WA; Rensen SS; Greve JW; van Schooten FJ
J Hepatol; 2013 Mar; 58(3):543-8. PubMed ID: 23142062
[TBL] [Abstract][Full Text] [Related]
11. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
[TBL] [Abstract][Full Text] [Related]
12. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
13. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath analysis in hepatology: State-of-the-art and perspectives.
De Vincentis A; Vespasiani-Gentilucci U; Sabatini A; Antonelli-Incalzi R; Picardi A
World J Gastroenterol; 2019 Aug; 25(30):4043-4050. PubMed ID: 31435162
[TBL] [Abstract][Full Text] [Related]
15. Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls.
Eng K; Alkhouri N; Cikach F; Patel N; Yan C; Grove D; Lopez R; Rome E; Dweik RA
J Breath Res; 2015 Apr; 9(2):026002. PubMed ID: 25891513
[TBL] [Abstract][Full Text] [Related]
16. Breath biomarkers of liver cirrhosis.
Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634
[TBL] [Abstract][Full Text] [Related]
17. Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study.
Ibrahim W; Wilde M; Cordell R; Salman D; Ruszkiewicz D; Bryant L; Richardson M; Free RC; Zhao B; Yousuf A; White C; Russell R; Jones S; Patel B; Awal A; Phillips R; Fowkes G; McNally T; Foxon C; Bhatt H; Peltrini R; Singapuri A; Hargadon B; Suzuki T; Ng LL; Gaillard E; Beardsmore C; Ryanna K; Pandya H; Coates T; Monks PS; Greening N; Brightling CE; Thomas P; Siddiqui S
BMJ Open; 2019 Mar; 9(3):e025486. PubMed ID: 30852546
[TBL] [Abstract][Full Text] [Related]
18. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
19. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence the volatile organic compound content in human breath.
Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
